2017-11-15T13:44:04-06:00 2016-12-31 BDO USA LLP 32125 SOLON ROAD SOLON OH 44139 990 2016-01-01 270486705 ALLIANCE FOR REGENERATIVE MEDICINE % THOMAS J DULA ALLI 2024192515 525 SECOND STREET NE WASHINGTON DC 20002 JANET LYNCH LAMBERT CEO 2024192515 2017-11-15 true MELANIE WERNERT P01258969 4402488787 2017-10-19 162.249.80.3 34986820173195000002 2017-11-15 P 8C70FE1CCBDA104FAEB314B1D455D5075C5F4CC1 8C70FE1CCBDA104FAEB314B1D455D5075C5F4CC1 2016 2017-02-10 21:41:12Z JANET LYNCH LAMBERT 525 SECOND STREET NE WASHINGTON DC 20002 3571721 false X WWW.ALLIANCERM.ORG X 2009 DC SEE SCHEDULE O 31 31 0 430 0 0 7109 2976080 3564512 61 100 0 0 2976141 3571721 0 0 0 0 0 0 0 0 0 2771703 3410335 2771703 3410335 204438 161386 1143330 1349510 855644 900438 287686 449072 X SEE SCHEDULE O false false 1289890 1776680 COMMUNICATIONS, CAPITAL FORMATION, AND OPERATIONS: TO DEVELOP PUBLICATIONS, SOCIAL MEDIA STRATEGIES, AND OTHER MATERIALS THAT WILL EDUCATE THE PUBLIC ABOUT REGENERATIVE MEDICINE. 1068358 1647832 POLICY, ADVOCACY, AND GOVERNMENT RELATIONS: TO PROVIDE MEETINGS AND WORKSHOPS THAT WILL ASSIST MEMBERS WITH GOVERNMENT RELATIONS AND REGULATORY DECISION MAKING. 423747 140000 SCIENCE AND TECHNOLOGY: TO DEVELOP CONSENSUS PRODUCT DEVELOPMENT AND REGULATORY STANDARDS, AND PROVIDE MORE EFFICIENT ACCESS TO INDUSTRY BEST-PRACTICES REGARDING MANUFACTURING AND SCALE-UP. 2781995 false false false true false false false false false true false false false false true true false false false false false false false false false false false false false false false false false false false false false false false false false false false false false true 10 0 0 false false false false true true false X 31 31 false true false false false true false true true false false false true true true false false false false false DC X THOMAS J DULA 7038551301 525 SECOND STREET NE WASHINGTON DC 20002 CLAUDIA ZYLBERBERG TREASURER 1.15 0.0 X X 0 0 0 PHIL VANEK SECRETARY 1.15 0.0 X X 0 0 0 BOB PRETI CHAIRMAN SINCE 08/04/16 1.54 0.0 X X 0 0 0 EDWARD LANPHIER CHAIRMAN UNTIL 08/04/16 1.15 0.0 X X 0 0 0 MATT PATTERSON VICE CHAIRMAN SINCE 08/04/16 0.67 0.0 X X 0 0 0 DOUG DOERFLER DIRECTOR 0.48 0.0 X 0 0 0 EDUARDO BRAVO DIRECTOR 0.29 0.0 X 0 0 0 FLAGG FLANAGAN DIRECTOR 0.29 0.0 X 0 0 0 CHRISTIAN HOMSY DIRECTOR 0.19 0.0 X 0 0 0 PERRY KARSEN DIRECTOR 0.04 0.0 X 0 0 0 DOUG KERR DIRECTOR 0.04 0.0 X 0 0 0 DENA LADD DIRECTOR 0.19 0.0 X 0 0 0 MARTIN ANDREWS DIRECTOR 0.12 0.0 X 0 0 0 MICHAEL MAY DIRECTOR 0.29 0.0 X 0 0 0 RANDY MILLS DIRECTOR 0.08 0.0 X 0 0 0 STEVE PAUL DIRECTOR 0.04 0.0 X 0 0 0 RAHUL ARAS DIRECTOR 0.29 0.0 X 0 0 0 ISABELLE RIVIERE DIRECTOR 0.12 0.0 X 0 0 0 MARTHA ROOK DIRECTOR 0.29 0.0 X 0 0 0 JAY SIEGEL DIRECTOR 0.29 0.0 X 0 0 0 MATTHIEU SIMON DIRECTOR 0.04 0.0 X 0 0 0 DAVID SMITH DIRECTOR 0.19 0.0 X 0 0 0 DEVYN SMITH DIRECTOR 0.12 0.0 X 0 0 0 DORIS TAYLOR DIRECTOR 0.04 0.0 X 0 0 0 KEITH THOMPSON DIRECTOR 0.12 0.0 X 0 0 0 GIL VAN BOKKELEN DIRECTOR 0.19 0.0 X 0 0 0 USMAN AZAM DIRECTOR 0.23 0.0 X 0 0 0 ALEXANDER VOS DIRECTOR 0.38 0.0 X 0 0 0 JEFF WALSH DIRECTOR 0.19 0.0 X 0 0 0 SUSAN WASHER DIRECTOR 0.19 0.0 X 0 0 0 ZAMI ABERMAN DIRECTOR 0.12 0.0 X 0 0 0 DONNA SKERRETT DIRECTOR 0.12 0.0 X 0 0 0 THOMAS J DULA CHIEF FINANCIAL OFFICER 6.0 0.0 X 46800 0 0 46800 0 0 0 false false false ADJUVANT PARTNERS LLC 1340 SMITH AVE SUITE 200 BALTIMORE MD 21209 STAFFING SERVICES 1578245 HOLLAND KNIGHT LLP 800 17TH STREET NW SUITE 1100 WASHINGTON DC 20006 STAFFING SERVICES 494014 ESTANCIA HOTEL 9700 NORTH TORREY PINES RD LA JOLLA CA 92037 EVENT SERVICES 255320 EXPERT SERVICE ADVICE ED VANDERVAERENSTRAAT 30A PO BOX 8 HOEILAART 0 BE 1560 MANAGEMENT SERVICES 155866 KORN FERRY INTERNATIONAL NW 5064 PO BOX 1450 MINNEAPOLIS MN 55485 STAFFING SERVICES 131182 5 7109 7109 MEMBERSHIP DUES 900099 1916680 1916680 STEM CELL CONFERENCE 900099 1084422 1084422 MEMBERSHIP MEETINGS 900099 327530 327530 REGENMED INVESTOR MEETING 900099 235880 235880 3564512 100 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3571721 3564512 100 0 0 0 0 0 0 0 0 0 0 405000 303750 101250 132149 94285 37864 67300 67300 558066 558066 0 0 414537 250433 164104 0 16633 16633 20385 20385 0 48000 48000 31883 21344 10539 0 1053907 1050939 2968 0 0 275 275 23647 23647 STRATEGIC PRIORITY 89939 82381 7558 MEMBERSHIP SUPPORT 175188 141890 33298 EUROPEAN UNION SECTION 183142 160434 22708 ADMIN./COMMITTEE SUPPORT 46747 13749 32998 143537 81077 62460 3410335 2781995 628340 0 266967 433746 267177 349000 0 0 602700 546555 0 0 0 0 0 0 0 0 5227 19225 1374 390 1259 984 0 0 0 0 0 0 0 0 0 0 1143330 1349510 70249 93749 0 0 783552 806689 0 0 0 0 0 0 0 0 0 0 1843 0 855644 900438 X 287686 449072 0 0 0 0 287686 449072 1143330 1349510 161386 X false true X true false false false false 1916680 558066 288924 846990 575004 271986 1374 390 984 984 0 0 X 3571721 3571721 3571721 3410335 3410335 3410335 PART X, LINE 2: THE ALLIANCE IS EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(4) OF THE INTERNAL REVENUE CODE. INCOME TAXES ON UNRELATED BUSINESS INCOME, IF ANY, ARE PROVIDED AT THE APPLICABLE RATES ON INCOME FOR FINANCIAL REPORTING PURPOSES. THE ALLIANCE HAS ADOPTED THE ACCOUNTING GUIDANCE FOR UNCERTAINTY IN INCOME TAXES. USING THAT GUIDANCE, TAX POSITIONS INITIALLY NEED TO BE RECOGNIZED IN THE FINANCIAL STATEMENTS WHEN IT IS MORE-LIKELY-THAN-NOT THE POSITION WILL BE SUSTAINED UPON EXAMINATION BY THE TAX AUTHORITIES. AS THE DECEMBER 31, 2016 AND 2015, THE ALLIANCE HAD NO UNCERTAIN TAX POSITIONS THAT QUALIFY FOR EITHER RECOGNITION OR DISCLOSURE IN THE FINANCIAL STATEMENTS. THE ALLIANCE'S INCOME TAX FILINGS ARE SUBJECT TO AUDIT BY VARIOUS TAXING AUTHORITIES. IN EVALUATING ITS ACTIVITIES, THE ALLIANCE BELIEVES ITS POSTION ON TAX-EXEMPT STATUS IS CURRENT BASED ON CURRENT FACTS AND CIRCUMSTANCES. THE ALLIANCE HAS ASSESSED THAT THERE ARE NO ACTIVTIES UNRELATED TO ITS PURPOSE AND, THEREFORE, NO TAX IS TO BE RECOGNIZED. IT IS THE POLICY OF THE ALLIANCE TO INCLUDE IN EXPENSES, PENALTIES AND INTEREST ASSESSED BY INCOME TAXING AUTHORITIES. THERE ARE NO PENALITES OR INTEREST FROM TAXING AUTHORITIES INCLUDED IN EXPENSES FOR THE YEAR ENDED DECEMBER 31, 2016 AND 2015. FORM 990, PART I, LINE 1: THE ALLIANCE FOR REGENERATIVE MEDICINE (ARM) IS THE PREEMINENT GLOBAL ADVOCATE FOR REGENERATIVE AND ADVANCED THERAPIES. ARM FOSTERS RESEARCH, DEVELOPMENT, INVESTMENT AND COMMERCIALIZATION OF TRANSFORMATIONAL TREATMENTS AND CURES FOR PATIENTS WORLDWIDE. BY LEVERAGING THE EXPERTISE OF ITS MEMBERSHIP, ARM EMPOWERS MULTIPLE STAKEHOLDERS TO PROMOTE LEGISLATIVE, REGULATORY AND PUBLIC UNDERSTANDING OF, AND SUPPORT OF, THIS EXPANDING FIELD. FORM 990, PART III, LINE 1: THE ALLIANCE FOR REGENERATIVE MEDICINE (ARM) IS THE PREEMINENT GLOBAL ADVOCATE FOR REGENERATIVE AND ADVANCED THERAPIES. ARM FOSTERS RESEARCH, DEVELOPMENT, INVESTMENT AND COMMERCIALIZATION OF TRANSFORMATIONAL TREATMENTS AND CURES FOR PATIENTS WORLDWIDE. BY LEVERAGING THE EXPERTISE OF ITS MEMBERSHIP, ARM EMPOWERS MULTIPLE STAKEHOLDERS TO PROMOTE LEGISLATIVE, REGULATORY AND PUBLIC UNDERSTANDING OF, AND SUPPORT OF, THIS EXPANDING FIELD. FORM 990, PART VI, LINE 3: ADJUVANT PARTNERS, LLC IS ENGAGED TO PROVIDE MANAGEMENT SERVICES FOR ALLIANCE FOR REGENERATIVE MEDICINE. FORM 990, PART VI, LINE 7A: THE GOVERNING BODY IS ELECTED BY THE MEMBERS AT THE ANNUAL MEETING THAT TAKES PLACE IN THE FALL EACH YEAR. FORM 990, PART VI, LINE 11B: THE TREASURER AND FINANCE COMMITTEE REVIEW THE TAX RETURN. FORM 990, PART VI, LINE 12C: THE CONFLICT OF INTEREST POLICY COVERS ANY DIRECTOR, PRINCIPAL OFFICER, OR MEMBER OF A COMMITTEE WITH GOVERNING BOARD DELEGATED POWERS. DISCLOSURE IS TO DIRECTORS AND MEMBERS OF COMMITTEES WITH GOVERNING BOARD DELEGATED POWERS. DISCLOSURES ARE REVIEWED AND MAINTAINED BY THE REMAINING MEMBERS OF THE GOVERNING BOARD OR COMMITTEE. THE GOVERNING BOARD OR COMMITTEE REVIEWS EACH TRANSACTION TO COME BEFORE THE BOARD FOR POTENTIAL OR ACTUAL CONFLICTS OF INTEREST. IF POTENTIAL OR ACTUAL CONFLICTS (PAST, PRESENT, OR FUTURE) ARE IDENTIFIED, THE CHAIR PERSON OF THE GOVERNING BOARD OR COMMITTEE SHALL, IF APPROPRIATE, APPOINT A DISINTERESTED PERSON OR COMMITTEE TO INVESTIGATE ALTERNATIVES TO THE PROPOSED TRANSACTION OR ARRANGEMENT. AFTER EXERCISING DUE DILIGENCE, THE GOVERNING BOARD OR COMMITTEE SHALL DETERMINE WHETHER THE ORGANIZATION CAN OBTAIN WITH REASONABLE EFFORTS A MORE ADVANTAGENOUS TRANSACTION OR ARRANGEMENT FROM A PERSON OR ENTITY THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST. THE IDENTIFIED CONFLICTS OF INTEREST AND APPROPRIATE RECUSALS ARE DOCUMENTED IN THE MINUTES OF EACH BOARD OR COMMITTEE MEETING. FORM 990, PART VI, LINE 19: THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC.